GCM
GSK icon

Gallacher Capital Management’s GSK GSK Stock Holding History

Gallacher Capital Management’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$436K Sell
8,312
-7,871
-49% -$416K 0.24% 136
2026
Q1 		$893K Buy
16,183
+414
+3% +$22.4K 0.34% 81
2025
Q4 		$773K Buy
15,769
+40
+0.3% +$1.87K 0.3% 86
2025
Q3 		$679K Buy
15,729
+3,156
+25% +$123K 0.27% 107
2025
Q2 		$483K Buy
12,573
+349
+3% +$13.3K 0.22% 130
2025
Q1 		$474K Buy
12,224
+943
+8% +$34.5K 0.23% 120
2024
Q4 		$382K Buy
11,281
+161
+1% +$5.8K 0.19% 145
2024
Q3 		$455K Buy
11,120
+356
+3% +$14.6K 0.21% 119
2024
Q2 		$414K Buy
10,764
+526
+5% +$22.1K 0.22% 120
2024
Q1 		$439K Buy
10,238
+223
+2% +$9.2K 0.22% 107
2023
Q4 		$371K Buy
10,015
+82
+0.8% +$2.94K 0.21% 122
2023
Q3 		$360K Buy
9,933
+174
+2% +$6.18K 0.22% 105
2023
Q2 		$348K Buy
9,759
+583
+6% +$20.9K 0.2% 139
2023
Q1 		$326K Buy
9,176
+1,399
+18% +$48.9K 0.2% 145
2022
Q4 		$273K Buy
+7,777
New +$259K 0.17% 154

Other funds holding GSK

LMFP
Larry Mathis Financial Planning Phoenix, Arizona $124B AUM
DLA
Douglas Lane & Associates New York $7.37B AUM 21.9% 1-Year Est. Return
TNB
Thomasville National Bank Thomasville, Georgia $1.82B AUM
AA
ABC Arbitrage Paris, France $926M AUM 45.9% 1-Year Est. Return
FVWA
Foster Victor Wealth Advisors Greenville, South Carolina $1.9B AUM 24.46% 1-Year Est. Return
SIS
Sound Income Strategies Ft Lauderdale, Florida $2.23B AUM 11.22% 1-Year Est. Return
KFP
Keystone Financial Planning Cleveland, Ohio $388M AUM 16.66% 1-Year Est. Return
QCM
QRG Capital Management Chicago, Illinois $12.1B AUM 44.98% 1-Year Est. Return
TH
Transmarket Holdings Chicago, Illinois $136M AUM
GC
Grimes & Company Westborough, Massachusetts $4.62B AUM 29.71% 1-Year Est. Return

Gallacher Capital Management's GSK Position: Q2 2026 in Review

Gallacher Capital Management reduced its GSK (GSK) stake by 49% in Q2 2026, selling an estimated $416K and leaving 8,312 shares worth $436K. The position accounts for 0.24% of the portfolio, ranked #136.

Gallacher Capital Management first reported a position in GSK in Q4 2022 and has held it in 15 quarters since. The position peaked at $893K in Q1 2026. 250 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

  • Gallacher Capital Management held 8,312 shares of GSK worth $436K as of Q2 2026.
  • Gallacher Capital Management sold 7,871 GSK shares in Q2 2026, an estimated $416K.
  • GSK made up 0.24% of Gallacher Capital Management's portfolio in Q2 2026, its #136 holding.
  • Gallacher Capital Management first reported a position in GSK in Q4 2022 and has held it in 15 quarters since.
  • Gallacher Capital Management's GSK position peaked at $893K in Q1 2026.
  • 250 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on Gallacher Capital Management's 13F filing for Q2 2026, filed 17 Jul 2026.